会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • INHIBITORS OF MEMAPSIN 2 AND USE THEREOF
    • MEMAPSIN 2的抑制剂及其用途
    • US20080021196A1
    • 2008-01-24
    • US11763342
    • 2007-06-14
    • Jordan TANGArun Ghosh
    • Jordan TANGArun Ghosh
    • C07C7/06C07C229/24
    • C07K5/1021A61K38/00A61K39/00C07K1/1136C07K5/06026C07K5/06043C07K5/0806C07K2299/00C12N9/6421C12N9/6478Y02A90/26Y10S514/879
    • Methods for the production of purified, catalytically active, recombinant memapsin 2 have been developed. The substrate and subsite specificity of the catalytically active enzyme have been determined. The substrate and subsite specificity information was used to design substrate analogs of the natural memapsin 2 substrate that can inhibit the function of memapsin 2. The substrate analogs are based on peptide sequences, shown to be related to the natural peptide substrates for memapsin 2. The substrate analogs contain at least one analog of an amide bond which is not capable of being cleaved by memapsin 2. Processes for the synthesis of two substrate analogues including isosteres at the sites of the critical amino acid residues were developed and the substrate analogues, OMR99-1 and OM99-2, were synthesized. OM99-2 is based on an octapeptide Glu-Val-Asn-Leu-Ala-Ala-Glu-Phe (SEQ ID NO:28) with the Leu-Ala peptide bond substituted by a transition-state isostere hydroxyethylene group (FIG. 1). The inhibition constant of OM99-2 is 1.6×10−9 M against recombinant pro-memapsin 2. Crystallography of memapsin 2 bound to this inhibitor was used to determine the three dimensional structure of the protein, as well as the importance of the various residues in binding. This information can be used by those skilled in the art to design new inhibitors, using commercially available software programs and techniques familiar to those in organic chemistry and enzymology, to design new inhibitors to memapsin 2, useful in diagnostics and for the treatment and/or prevention of Alzheimer's disease.
    • 已经开发了用于生产纯化的,催化活性的重组突变蛋白2的方法。 已经确定了催化活性酶的底物和亚位点特异性。 底物和亚位点特异性信息用于设计可以抑制膜蛋白2功能的天然memapsin 2底物的底物类似物。底物类似物基于肽序列,显示与memapsin 2的天然肽底物相关。 底物类似物含有至少一个酰胺键的类似物,该类似物不能被膜蛋白2切割。开发了两个底物类似物合成的关键氨基酸残基位点处的等位基因,底物类似物OMR99- 1和OM99-2。 OM99-2基于由过渡态等电位羟基亚乙基取代的Leu-Ala肽键的八肽Glu-Val-Asn-Leu-Ala-Ala-Glu-Phe(SEQ ID NO:28)(图1 )。 OM99-2的抑制常数相对于重组pro-memapsin为1.6×10 -9 M。使用与该抑制剂结合的胶原蛋白2的结晶学来确定蛋白质的三维结构,以及 各种残留物在结合中的重要性。 本领域技术人员可以使用本信息来设计新的抑制剂,使用商业上可获得的有机化学和酶学方面熟悉的软件程序和技术来设计新的抑制剂2,可用于诊断和治疗和/或 预防阿尔茨海默病。